EUVIMEDEUVIMED entdecken
Crossref

From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU

Von InSurE zu MIST: Eine Quality-Improvement-Initiative in einer Level-IV-NICU

Natasha Ahn, Emiko Yamada, Kellie Barsotti, Walid Hussain iD

American Journal of Perinatology · 30.06.2026

DOI: 10.1055/a-2901-2777 ↗

Auf einen Blick

In einer Level-IV-NICU stieg die MIST-Nutzung innerhalb von 1 Jahr von 3 % auf 97 %. Die Intubation innerhalb von 7 Tagen blieb unverändert, die prämedikamentöse Gabe nahm ab.

Fragestellung

Kann die Nutzung von MIST in einer Level-IV-NICU gesteigert werden, und welchen Einfluss hat das auf Versorgungsprozesse und klinische Outcomes?

Methode

Quality-Improvement-Initiative mit SMART-Ziel; Standardisierung, Kits, interdisziplinäre Schulung und PDSA-Zyklen mit Audits und Debriefings.

Ergebnisse

MIST stieg von 3 % auf 97 % der geeigneten Kinder innerhalb von 1 Jahr. Intubation innerhalb von 7 Tagen: 19 % vs. 18 %. Prämedikation: 17 % vs. 1 % (p = 0,002).

Schlussfolgerung der Autor:innen

Ein strukturierter, multidisziplinärer QI-Ansatz war mit erhöhter und anhaltender MIST-Nutzung sowie einem Wechsel zu nichtinvasiver Surfactant-Gabe verbunden. Die Implementierung in einer Hochakuitäts-NICU war machbar.

Kernaussagen

  • MIST-Nutzung stieg innerhalb von 1 Jahr von 3 % auf 97 %
  • Intubation innerhalb von 7 Tagen blieb mit 19 % vs. 18 % unverändert
  • Prämedikation sank von 17 % auf 1 % (p = 0,002)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, online erschienen am 30.06.2026. Verfasst von Natasha Ahn und 3 weiteren Autor:innen. Beteiligte Einrichtung: Comer Children's Hospital, University of Chicago Medicine, Section of Neonatology, Department of Pediatrics, United States. Gefördert von: Chiesi Farmaceutici.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Mechanical ventilation is a key modifiable risk factor for bronchopulmonary dysplasia (BPD) in preterm infants with respiratory distress syndrome (RDS). Minimally invasive surfactant therapy (MIST) enables surfactant delivery to spontaneously breathing infants. MIST use has been associated with lower rates of adverse outcomes, including death and BPD; however, uptake in the U.S. neonatal intensive care units (NICUs) has been variable. At our level IV NICU, Intubate, Surfactant, Extubate (InSurE) was the standard method for surfactant delivery in infants on non-invasive respiratory support. We aimed to increase MIST utilization and evaluate its impact on respiratory care practices and clinical outcomes. Study Design A quality improvement (QI) initiative was launched with a specific, measurable, achievable, relevant, and time-bound (SMART) aim to increase MIST use from 3% to 80% within 1 year. Interventions included the development of standardized guidelines, creation of procedural kits, multidisciplinary education, and identification of clinical champions. Iterative Plan–Do–Study–Act (PDSA) cycles were supported by real-time audits and structured debriefings. Primary process measure was MIST utilization; secondary measures included procedural adherence, intubation within 7 days, and pharmacologic premedication use as a balancing measure.

Results

MIST use increased from 3% to 97% of eligible infants within 1 year, with special cause variation and sustained centerline shift on p-chart analysis. Procedural adherence was high, with only minor single-step deviations on audit. The rate of intubation within 7 days of surfactant administration was unchanged pre- and post-MIST implementation (19% vs. 18%). Pharmacologic premedication use decreased significantly from 17% to 1% (p = 0.002). At the system level, the proportion of infants receiving surfactant via intubation decreased from 71% to 37%, reflecting a shift toward non-invasive respiratory management.

Conclusion

A structured, multidisciplinary QI approach was associated with increased and sustained use of MIST and a shift toward noninvasive surfactant delivery. This initiative demonstrates the feasibility of implementing MIST in a high acuity level IV NICU. Key Points Comparison of MIST versus InSurE. The effects of invasive ventilation. The use of sedation during MIST.

Autor:innen und Institutionen

  • Comer Children's Hospital, University of Chicago Medicine, Section of Neonatology, Department of Pediatrics, United States.
  • Doernbecher Children's Hospital at Oregon Health & Science University, Section of Neonatology, Department of Pediatrics, United States.

ORCID-Profile: Walid Hussain

Förderung

  • Chiesi Farmaceutici

Zitieren

APA

Ahn, N., Yamada, E., Barsotti, K., & Hussain, W. (2026). From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU. American Journal of Perinatology. https://doi.org/10.1055/a-2901-2777

Vancouver

Ahn N, Yamada E, Barsotti K, Hussain W. From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU. American Journal of Perinatology. 2026. doi:10.1055/a-2901-2777

BibTeX
@article{Ahn2026,
  author = {Ahn, Natasha and Yamada, Emiko and Barsotti, Kellie and Hussain, Walid},
  title = {From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU},
  journal = {American Journal of Perinatology},
  year = {2026},
  doi = {10.1055/a-2901-2777}
}
Kostenlos starten →